Day: January 29, 2024

Announces Latest Contract Awards HOUSTON, Jan. 29, 2024 (GLOBE NEWSWIRE) — Orion Group Holdings, Inc. (NYSE: ORN) (the “Company”), a leading specialty construction company, today announced the rebranding of its subsidiary TAS Concrete Construction (“TAS”) as Orion. This move reflects the Company’s strategic initiative to integrate its different service offerings under one banner to leverage Orion’s brand reputation and to deliver greater value and seamless execution for its customers. TAS Concrete Construction was acquired by Orion Group Holdings, Inc. in 2015 and has continued to operate under the TAS name until now. The Company’s concrete segment, formerly known as TAS, and its marine segment will now operate together under the Orion name providing its customers with a single source for specialty construction and engineering. “By...

TORONTO, Jan. 29, 2024 (GLOBE NEWSWIRE) — Abaxx Technologies Inc. (NEO:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, producer of the SmarterMarkets™ Podcast, and indirect majority shareholder of Abaxx Singapore Pte Ltd. (“Abaxx Singapore”), the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing”), announces that Abaxx Singapore Pte. Ltd has been approved for membership into the Futures Industry Association (FIA). The FIA is a global trade organization with a diverse membership base, including clearing firms, exchanges, clearing houses, and trading firms from over 48 countries, along with various professionals serving the industry with the mission to support open, transparent and competitive markets, protect and enhance...

Lantronix PoE++ Switch to be Displayed at BICSI IRVINE, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global provider of secure turnkey solutions for the Industrial Internet of Things (IoT) and the Intelligent IT market, today announced that it has won an IoT Evolution Smart Buildings Innovation Award for its Smart Managed Gigabit Power over Ethernet++ (PoE++) SM24TBT2DPB PoE++ Switch. The Lantronix POE++ switch will be displayed at the upcoming 2024 BICSI Winter Conference being held Jan. 28 to Feb. 1, 2024, at Rosen Shingle Creek in Orlando, Fla. Lantronix will be at booth #816. Presented by IoT Evolution World, the leading online publication covering IoT technologies, the Smart Buildings Innovation Awards acknowledge and showcase companies behind the innovations that transform the way we design, construct,...

TORONTO, Ontario and BROSSARD, Québec, Jan. 29, 2024 (GLOBE NEWSWIRE) — Bitfarms Ltd. (NASDAQ: BITF // TSX: BITF), a global Bitcoin self-mining company, announced today that Bitfarms’ management and directors, led by President & CEO Geoff Morphy and co-founders Nicolas Bonta and Emiliano Grodzki, will ring the closing bell at Nasdaq MarketSite in New York’s Time Square on Tuesday, January 30th, 2024 at 4:00 pm ET. “We are honored to celebrate our listing on Nasdaq, which commenced in June 2021,” said Geoff Morphy. “Achieving a dual-listing status has provided us access to a broader set of institutional investors and enabled us to increase trading liquidity. Ringing the closing bell highlights our 2023 ranking as the 8th top performing stock on Nasdaq, our transformational growth strategy, and our strong trajectory...

Further expands clinical development of FasTCAR-T GC012F in multiple myeloma amid ongoing U.S. trial evaluating therapy for treatment of relapsed/refractory multiple myeloma SAN DIEGO and SUZHOU, China and SHANGHAI, China, Jan. 29, 2024 (GLOBE NEWSWIRE) — Gracell Biotechnologies Inc. (“Gracell” or the “Company”, NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing innovative and highly efficacious cell therapies for the treatment of cancer and autoimmune disease, today announced that the U.S. Food and Drug Administration (FDA) has cleared Gracell’s Investigational New Drug (IND) application, allowing the Company to initiate a Phase 1 clinical trial of GC012F in the United States for the early-line treatment of multiple myeloma (ELMM). “We are extremely pleased to receive our third U.S. IND clearance...

BAUDETTE, Minn., Jan. 29, 2024 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will participate in a fireside chat at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference in New York City as follows:Date:   Thursday, February 8, 2024     Time:   10:30 a.m. ET     Webcast:   Click Here     To schedule a 1×1 meeting with the Company, please email: gsmanagementaccess@guggenheimpartners.com The live and archived webcast will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 30 days. About ANI ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical...

Pittsburgh, PA, Jan. 29, 2024 (GLOBE NEWSWIRE) — Himalaya Technologies, Inc.’s (OTC: HMLA; “Himalaya”) Infood Technologies, Inc. unit (“Infood”; https://www.infood.tech/) has substantially expanded its aquaponics offering by adding new features for K12 customers and by introducing microfarms and commercial systems. The additions allow Infood to target larger customer orders including K12 schools seeking to introduce broader classroom training and offer nutrition to their student populations, food pantries and missions that feed local residents, and for-profit operators seeking to sell produce and fish protein in their local markets. As part of this expanded product set, the Company has been named a Preferred Dealer by a premiere global vendor of aquaponics systems in several dozen countries. Infood’s Aquaponics Systems now include...

ZUG, Switzerland and BOSTON, Jan. 29, 2024 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that Oculis’ management will be attending and presenting at the following upcoming investor conferences: Stifel Biotech Executive Summit Format: Fireside chat Presenter: Riad Sherif, MD, Chief Executive OfficerPresentation date and time: February 7, 2024 at 7:30 am MT (Mountain Time)Location: Pendry Park City, Park City, Utah, USA BioCapital Europe 2024Format: Company presentation Presenter: Sylvia Cheung, Chief Financial OfficerPresentation date and time: February 8, 2024 at 11:40 am CET (Central European Time) Location: Hotel Sofitel Legend The Grand Amsterdam, Amsterdam, Netherlands The Company will be available for...